• The document is a regulatory filing submitted to BSE and NSE containing the Investor Presentation for the first quarter ended June 30, 2026 (Q1 FY27).
  • The presentation was filed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The company has uploaded the presentation on its website as per compliance requirements.
  • The document contains extensive financial results and operational updates for Q1 FY27.

Financial Highlights

Quarterly Performance (Q1 FY27 vs Q1 FY26)

  • Revenue: ₹300.45 crore, up 24.90% from ₹240.55 crore
  • EBITDA: ₹56.43 crore, up 19.11% from ₹47.37 crore
  • PAT: ₹25.57 crore, up 14.19% from ₹22.39 crore
  • EPS: ₹7.70, up 14.18% from ₹6.74
  • Sales Volume: 12,089 MT, up 6.25% from 11,378 MT
  • EBITDA Margin: 18.78% (down 92 bps from 19.70%)
  • PAT Margin: 8.51% (down 80 bps from 9.31%)

Cost Breakdown (Q1 FY27)

  • Material Cost: ₹176.33 crore (up 32% YoY)
  • Employee Expense: ₹20.24 crore (up 13% YoY)
  • Other Expense: ₹48.02 crore (up 15% YoY)
  • Other Income: ₹0.58 crore (down 3% YoY)

Quarterly Comparison (Q1 FY27 vs Q4 FY26)

  • Revenue up 26% from ₹237.86 crore
  • EBITDA up 17% from ₹48.10 crore
  • PAT up 24% from ₹20.64 crore
  • Sales Volume: Comparative data not provided for Q4

Annual Performance (FY26 vs FY25)

  • Revenue: ₹886.61 crore, up 13% from ₹781.32 crore
  • EBITDA: ₹173.66 crore, up 21% from ₹143.86 crore
  • PAT: ₹72.87 crore, up 20% from ₹60.56 crore
  • EBITDA Margin: 19.59% (up 117 bps from 18.41%)
  • PAT Margin: 8.22% (up 47 bps from 7.75%)

Operational Highlights

Business Overview

  • Established in 1986, publicly listed in 1993
  • Leading player in rigid plastic packaging in India
  • 10 Manufacturing Units, 1 stock point PAN India
  • Current installed Injection molding capacity: 66,900 TPA
  • Pioneers in In-Mold labelling (IML) in India
  • Major customers include Asian Paints, Castrol, Shell, Mondelez, Hindustan Unilever

Strategic Initiatives

  • Consolidated 5 plants into 2 locations for better EBITDA growth
  • Product mix expansion into Panipat, Cheyyar, Daman & Satara
  • Continued R&D focus with new metallized IML, new shapes for F&FMCG, automation through camera inspection and AI
  • Successfully managed supply chain challenges during global disruptions

Segment Performance

  • Pharma segment: 40% growth in Q1 FY27, achieving Year 2 targets
  • Moving towards more stable and well-rounded product mix

Key Metrics

  • EBITDA per KG: ₹46.68 in Q1 FY27 (up 12% from ₹41.64 in Q1 FY26)
  • Cash PAT: ₹42.12 crore in Q1 FY27 (up 16% from ₹36.43 crore in Q1 FY26)
  • Cash Margin: 14.02% in Q1 FY27 (down 113 bps from 15.15% in Q1 FY26)

Additional Notes

  • The document is signed by J. Lakshmana Rao, Chairman and Managing Director (DIN: 00649702)
  • Dated July 27, 2026, with digital signature timestamp
  • The presentation includes detailed financial tables with YoY and QoQ comparisons
  • The document focuses solely on historical financial results and operational updates without forward-looking guidance